Epoch Investment Partners, Inc.Epoch Investment Partners, Inc.

Institutional investor · Portfolio as of Q1 2026

SEC EDGAR SourceSEC Filings

Top Holdings234 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

NVIDIA CORP

2.1M$369.8M2.2%$138.18+30.30%
20 qtrssince 2021-Q2
Decreased
0

ABBVIE INC

1.5M$327.6M2.0%$129.51+65.37%
29 qtrssince 2019-Q1
Increased
54

BROADCOM INC

1M$315.5M1.9%$156.55+100.48%
29 qtrssince 2019-Q1
Decreased
0

APPLE INC

1.2M$312.6M1.9%$201.84+25.51%
29 qtrssince 2019-Q1
Decreased
0

MICROSOFT CORP

788,663$291.9M1.8%$213.78+88.94%
29 qtrssince 2019-Q1
Decreased
0

META PLATFORMS INC-CLASS A

432,760$247.6M1.5%$236.15+177.40%
29 qtrssince 2019-Q1
Decreased
0

JPMORGAN CHASE & CO

800,542$235.5M1.4%$124.65+140.89%
24 qtrssince 2020-Q2
Decreased
0

APPLIED MATERIALS INC

659,689$225.5M1.4%$141.85+140.65%
29 qtrssince 2019-Q1
Decreased
0

ALPHABET INC-CL A

723,866$208.2M1.3%$117.68+157.97%
29 qtrssince 2019-Q1
Decreased
0

CISCO SYSTEMS INC

2.6M$205.2M1.2%$52.32+46.94%
29 qtrssince 2019-Q1
Increased
54

HCA HOLDINGS INC

412,897$195.4M1.2%$289.67+87.04%
12 qtrssince 2023-Q2
Decreased
0

EMCOR GROUP INC

262,823$194M1.2%$458.43+60.89%
7 qtrssince 2024-Q3
Decreased
0

REGENERON PHARMACEUTICALS

238,725$184.4M1.1%$834.25-8.10%
9 qtrssince 2024-Q1
Decreased
0

ACCENTURE PLC-CL A

902,498$179M1.1%$248.19-21.72%
29 qtrssince 2019-Q1
Increased
61

NETAPP INC

1.7M$178.6M1.1%$72.21+36.82%
17 qtrssince 2022-Q1
Increased
51

FABRINET

322,350$168.1M1.0%$222.72+148.31%
11 qtrssince 2023-Q3
Decreased
0
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

494,355$167.1M1.0%$101.98+246.27%
29 qtrssince 2019-Q1
Increased
48

UBER TECHNOLOGIES INC

2.3M$162.9M1.0%$68.02+12.26%
15 qtrssince 2022-Q3
Decreased
0

KLA CORP

110,231$162.3M1.0%$22.57+551.66%
29 qtrssince 2019-Q1
Decreased
0

DELL TECHNOLOGIES -C

964,040$158.2M1.0%$59.41+174.96%
13 qtrssince 2023-Q1
Decreased
0
$16.5B
AUM
234
Positions
Q1 2026
Filing
Rating · 2.5
Quarterly Portfolio Change
-8%Q4'24$20.6B-7%Q1'25$19.3B+0%Q2'25$19.3B-6%Q3'25$18.2B-3%Q4'25$17.6B-6%Q1'26$16.5B
Activity profile
$ moved · Q1'26
New10%Increased17%Decreased68%Exited5%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 5.0 years
<1Q4%1-4Q5%1-2Y4%2Y+86%

Epoch Investment Partners, Inc. manages $16.5B across 234 positions as of Q1 2026. Top holdings: NVDA (2.2%), ABBV (2.0%), AVGO (1.9%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 2.5/5.0.

Q1 2026 Summary

Active quarter - 19 new positions, 32 exits, 60 increased. Top move: ACN (INCREASED, conviction 61). Portfolio: $16.5B across 234 positions.

Top holdings by portfolio weight

Total AUM$17B
NVDA2.24%
ABBV1.98%
AVGO1.91%
AAPL1.89%
MSFT1.77%
META1.50%
JPM1.43%
AMAT1.37%
GOOGL1.26%
CSCO1.24%
Other1.18%

Portfolio allocation by GICS sector

Sectors11
Technology26.65%
Healthcare15.29%
Industrials11.45%
Financial Services11.09%
Consumer Cyclical9.62%
Communication Services6.63%
Energy5.42%
Consumer Defensive5.01%
Utilities4.12%
Basic Materials2.44%
Other2.27%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Technology, Healthcare, Industrials
Compare DNA across all funds
7-dimension quality assessment
Solid(2.5 / 5.0)
Track Record75
Conviction38
Concentration29
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
JKHYJKHYJACK HENRY & ASSOCIATES INC
Q2 2025 Q2 2026+534,337 shares+$60.4M
5Q
ACNACNACCENTURE PLC-CL A
Q2 2025 Q2 2026+809,293 shares+$49.1M
4Q
MKCMKCMCCORMICK & CO-NON VTG SHRS
Q3 2025 Q2 2026+661,860 shares+$24.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used